XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

160 hedge funds and large institutions have $1.03B invested in Intersect ENT, Inc in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 67 increasing their positions, 50 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.19M
Puts
$3.41M
Net Calls
Net Calls Change

Top Buyers

1 +$30.1M
2 +$17.3M
3 +$14.9M
4
BlackRock
BlackRock
New York
+$13.9M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$13M

Top Sellers

1 -$20.1M
2 -$19.6M
3 -$13.6M
4
Millennium Management
Millennium Management
New York
-$8.89M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$8.45M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$291K
127
$270K
128
$267K
129
$252K
130
$249K
131
$247K
132
$242K
133
$230K
134
$230K
135
$225K
136
$222K
137
$212K
138
$197K
139
$175K
140
$150K
141
$149K
142
$149K
143
$127K
144
$92K
145
$85K
146
$83K
147
$60K
148
$37K
149
$35.9K
150
$35K